Share This Page
Drug Price Trends for SM COLD-FLU SEVERE CAPLET
✉ Email this page to a colleague
Average Pharmacy Cost for SM COLD-FLU SEVERE CAPLET
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SM COLD-FLU SEVERE CAPLET | 70677-0100-01 | 0.10371 | EACH | 2024-06-19 |
| SM COLD-FLU SEVERE CAPLET | 70677-0100-01 | 0.11049 | EACH | 2024-04-17 |
| SM COLD-FLU SEVERE CAPLET | 70677-0100-01 | 0.12583 | EACH | 2024-03-20 |
| SM COLD-FLU SEVERE CAPLET | 70677-0100-01 | 0.11339 | EACH | 2024-02-21 |
| SM COLD-FLU SEVERE CAPLET | 70677-0100-01 | 0.14375 | EACH | 2024-01-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
SM COLD-FLU SEVERE CAPLET Market Analysis and Financial Projection
Market Analysis and Price Projections for Tylenol Cold & Flu Severe Caplets
Market Overview
The cold and flu medication market is a robust and growing sector, driven by seasonal variations, outbreaks, and increasing consumer awareness of over-the-counter (OTC) medications. Here’s a detailed analysis of the market and price projections for Tylenol Cold & Flu Severe Caplets.
Global Cold and Flu Drugs Market
The global cold and flu drugs market was valued at USD 15.76 billion in 2023 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 10.86% from 2024 to 2030, reaching nearly USD 32.43 billion by 2030[3].
Regional Market Dynamics
- Asia-Pacific: This region holds the largest market share and is expected to witness significant growth, driven by rising patient awareness of OTC medications and the rapid expansion of the Chinese economy[3].
- Europe: The European market holds the second-largest share, with a growing demand for supplements due to shifting parental choices towards preventative healthcare. Germany dominates the market share, while the UK exhibits the highest growth rate in the region[3].
Product Details: Tylenol Cold & Flu Severe Caplets
Tylenol Cold & Flu Severe Caplets are designed to provide temporary relief from a range of cold and flu symptoms, including fever, headache, minor aches and pains, sore throat, nasal congestion, and cough. Each caplet contains:
- Acetaminophen 325 mg: Pain reliever and fever reducer
- Dextromethorphan HBr 10 mg: Cough suppressant
- Guaifenesin 200 mg: Expectorant
- Phenylephrine HCl 5 mg: Nasal decongestant[1][2][5].
Market Positioning
Tylenol, being the #1 doctor-recommended pain relief brand, holds a significant market position. The brand's reputation and the effectiveness of its products contribute to its market dominance. Tylenol Cold & Flu Severe Caplets are widely available and suitable for adults and children 12 years and older[2].
Price Projections
Given the growing demand and market trends, here are some key points to consider for price projections:
Demand and Supply
- The increasing demand for cold and flu medications, particularly during peak flu seasons, is expected to drive prices. However, the supply chain, which includes major pharmaceutical companies and their production capacities, will also influence pricing.
- The Asia-Pacific region's growing market share and the European market's focus on preventative healthcare are likely to maintain or increase the demand for products like Tylenol Cold & Flu Severe Caplets[3].
Regulatory Factors
- The FDA's proposed order to remove oral phenylephrine from the OTC monograph, although not related to safety, could impact the formulation and pricing of these caplets in the future. However, this change is not expected to significantly alter the current market dynamics immediately[1][5].
Competitive Landscape
- The cold and flu supplements market, which includes both OTC medications and natural supplements, is expected to grow at a CAGR of 11.5% from 2023 to 2030. This growth indicates a competitive but expanding market where prices may remain stable or increase slightly due to high demand[4].
Price Trends
Current Pricing
As of the current market, Tylenol Cold & Flu Severe Caplets are priced competitively, reflecting their market position and the value they offer to consumers. For example, a 24-count package is generally priced around $10-$15, depending on the retailer and location[2].
Future Projections
Given the expected growth in the cold and flu drugs market, prices for Tylenol Cold & Flu Severe Caplets may see a moderate increase. Here are some potential scenarios:
- Stable Pricing: If the supply chain remains robust and demand is met efficiently, prices could remain stable, around $10-$15 per 24-count package.
- Moderate Increase: With increasing demand and potential regulatory changes, prices might rise by 5-10% over the next few years, reaching $11-$16.50 per 24-count package.
- High Demand Scenario: In the event of severe flu outbreaks or increased consumer awareness, prices could rise more significantly, potentially by 15-20%, reaching $12-$18 per 24-count package[3][4].
Key Takeaways
- The global cold and flu drugs market is expected to grow significantly, driven by seasonal variations and increasing consumer awareness.
- Tylenol Cold & Flu Severe Caplets hold a strong market position due to their effectiveness and the brand's reputation.
- Prices are likely to remain stable or see a moderate increase due to growing demand and potential regulatory changes.
- Regional market dynamics, particularly in the Asia-Pacific and European regions, will continue to influence the overall market.
FAQs
Q: What are the active ingredients in Tylenol Cold & Flu Severe Caplets?
A: The active ingredients include acetaminophen (325 mg), dextromethorphan HBr (10 mg), guaifenesin (200 mg), and phenylephrine HCl (5 mg)[1][2][5].
Q: Who is the target audience for Tylenol Cold & Flu Severe Caplets?
A: These caplets are suitable for adults and children 12 years and older[1][2][5].
Q: What is the expected growth rate of the global cold and flu drugs market?
A: The market is expected to grow at a CAGR of 10.86% from 2024 to 2030[3].
Q: How might regulatory changes affect the pricing of Tylenol Cold & Flu Severe Caplets?
A: The FDA's proposed order to remove oral phenylephrine from the OTC monograph could impact the formulation and pricing, but this is not expected to significantly alter current market dynamics immediately[1][5].
Q: What factors are driving the growth of the cold and flu supplements market?
A: The growth is driven by shifts in lifestyle, easier availability of supplements, growing consumer awareness of natural ingredients, and rising purchasing power of consumers worldwide[4].
Sources
- TYLENOL. TYLENOL® Cold & Flu Severe Caplets. Retrieved from https://www.tylenol.com/products/cold-flu/tylenol-cold-flu-severe-caplets
- Target. Tylenol Cold & Flu Severe Multi Symptom Caplets - 24ct. Retrieved from https://www.target.com/p/tylenol-cold-flu-severe-multi-symptom-caplets-acetaminophen-24ct/-/A-14013767
- Stellar Market Research. Cold and Flu Drugs Market: Industry Analysis and Forecast (2024-2030). Retrieved from https://www.stellarmr.com/report/Cold-and-Flu-Drugs-Market/1891
- Grand View Research. Cold And Flu Supplements Market Size & Share Report 2030. Retrieved from https://www.grandviewresearch.com/industry-analysis/cold-flu-supplements-market
- TYLENOL. TYLENOL® Cold & Flu Severe Caplets. Retrieved from https://www.tylenol.com/products/cold-flu/tylenol-cold-flu-severe-caplets?banner=2014mil1&bvstate=pg%3A2%2Fct%3Ar&bvroute=Reviews%2FshowHelpfulPositive
More… ↓
